At a glance
- Originator Bristol-Myers Squibb
- Class Antihypertensives
- Mechanism of Action Angiotensin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 17 Jul 1998 No-Development-Reported for Hypertension in USA (unspecified route)
- 25 Oct 1995 Preclinical development for Hypertension in USA (unspecified route)